private:xeneticbiosciencesplc-2
|
1467808
|
Jun 4th, 2019 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
145
|
5.00
|
Open
|
Biotechnology
|
Jun 4th, 2019 03:03PM
|
Jun 4th, 2019 03:03PM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
Open
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 17th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 16th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 15th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 14th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 13th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 12th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 11th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 10th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|
private:xeneticbiosciencesplc-2
|
1467808
|
Feb 9th, 2018 12:00AM
|
Xenetic Biosciences PLC (formerly Lipoxen PLC)
|
142
|
6.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.
Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen, Oncohist and ImuXen platform technologies.
|
|
|
|
|
|
|
|
|
|
Xenetic Biosciences PLC
|
|
|